XM does not provide services to residents of the United States of America.

Futures jump as megacaps recover; inflation data awaited for policy cues



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Futures jump as megacaps recover; inflation data awaited for policy cues</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

Russell 2000 futures jump

Deckers, Baker Hughes climb after results

Dexcom slips after cutting revenue forecast

PCE inflation data due at 8:30 a.m. ET

Futures up: Dow 0.62%, S&P 500 0.75%, Nasdaq 0.98%

Updated at 7:09 a.m. ET/1109 GMT

By Ankika Biswas and Lisa Pauline Mattackal

July 26 (Reuters) - Wall Street futures rose on Friday, with Nasdaqfutures up nearly 1% as megacap tech and chip stocks rebounded after the week's walloping, while investors awaited U.S. inflation figures to justify bets on early rate cuts by the Federal Reserve.

All the so-called Magnificent Seven stocks - Apple AAPL.O, Nvidia NVDA.O, Alphabet GOOGL.O, Microsoft MSFT.O, Meta Platforms META.O, Amazon.com AMZN.O and Tesla TSLA.O - were up between 0.7% and 2.2% in premarket trading.

Chip stocks also rebounded, with Intel INTC.O, Broadcom AVGO.O, Qualcomm QCOM.O, Micron Technology MU.O and Arm Holdings ARM.O up between 1% and 2%.

At 7:09 a.m. ET, Dow e-minis 1YMcv1 were up 248 points, or 0.62%, S&P 500 e-minis EScv1 were up 41 points, or 0.75%, and Nasdaq 100 e-minis NQcv1 were up 186 points, or 0.98%.

Investors have dumped tech stocks over thepast few weeks, with disappointing earnings from Alphabet and Tesla sparking a sharp sell-offin megacap and artificial-intelligence-linked stockson Wednesday. The S&P 500 and the Nasdaq were on track for asecond straight weekly decline, if losses hold.

Concerns about WallStreet's growing dependence on a set of high-momentum stocks, whose valuations now appear inflated, have made underperformingsectors like mid- and small-cap stocks seem morealluring as the prospectof early rate cuts rises.

Futures tracking the small-cap Russell 2000 RTYcv1 jumped1.4% on Friday, with the index set for its third straight week of gains if trends hold.

"A brutal rotation from U.S. information technology leaders to U.S. small caps has encouraged the narrative of a healthy rotation and a Goldilocks scenario for equities," Yves Bonzon, chief investment officer at Julius Bar said in a note.

However, Bonzon said he remained wary, noting that "the odds of a correction are higher than those of a sustainable rotation".

The much-awaited Personal Consumption Expenditures Price Index data - the Fed's preferred inflation gauge - will be watched to see if inflation cools further. Recent signs of easing inflation and a weakening labor market have boosted bets on an early start to the Fed's interest-rate cuts.

Traders have priced in around two rate cuts by December, according to LSEGdata, while bets of a 25-basis-point cut by the Fed's September meeting stood at 88%, according to CME's FedWatch.

The Commerce Department's report, due at 8:30 a.m. ET, is expected to show the PCE print rose0.1% on a monthly basis in June after last month's flat reading. Excluding volatile items such asfood and energy, the core figure is expected to increase0.1%, after a similar rise in May.

Earlier this week, data showing faster-than-expected second-quarter economic growth and subsiding inflation pressures kept hopes of a September rate cut intact, boosting the blue-chip Dow and the small-cap Russell 2000 .RUT.

On the earnings front, Deckers Outdoor DECK.N jumped 11% after raising its annual profit forecast following a first-quarter results beat, while Oilfield services firm Baker Hughes BKR.O climbed 2% after beating estimates for second-quarter profit.

Medical device maker Dexcom DXCM.O slumped 35.3% after cutting its annual revenue forecast, while drugmaker Bristol Myers Squibb BMY.N rose4.7% after better-than-expected second-quarterresults.

Investors also kept an eye out for developments in the U.S. presidential race, with new opinion polls showing Vice President Kamala Harris narrowing the gap with Republican rival Donald Trump.



Reporting by Ankika Biswas and Lisa Mattackal in Bengaluru; Editing by Saumyadeb Chakrabarty and Pooja Desai

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.